---
figid: PMC7820759__fimmu-11-586796-g004
figtitle: Schematic view of the molecular network and functions of human papillomavirus
  (HPV) E5, E6, and E7 oncoproteins in HPV-induced cancers
organisms:
- Adenoviridae
- Human papillomavirus
- Human papillomavirus type 16
- Vaccinia virus
- DNA viruses
- Semliki Forest virus
- Human papillomavirus types
- Modified Vaccinia Ankara virus
- Potato virus X
- Subgroup A
- Human papillomavirus type 6
- Escherichia coli
- Listeria monocytogenes
- Lactiplantibacillus plantarum
- Lacticaseibacillus casei
- Lactobacillus delbrueckii subsp. lactis
- Saccharomyces cerevisiae
- Komagataella pastoris
- Homo sapiens
- Mus musculus
- Bombyx mori
pmcid: PMC7820759
filename: fimmu-11-586796-g004.jpg
figlink: pmc/articles/PMC7820759/figure/f4/
number: F4
caption: Schematic view of the molecular network and functions of human papillomavirus
  (HPV) E5, E6, and E7 oncoproteins in HPV-induced cancers. E5, E6, and E7 oncoproteins
  are responsible for the carcinogenesis and tumorigenesis of HPV-induced cancers
  via activating multiple signaling pathways, such as cell cycle signaling, EGFR pathway,
  migration, and invasion pathways, p53 pathway and some epigenetic pathway. AKT,
  AKT serine/threonine kinases; B-MYB, MYB proto-oncogene like 2, MYBL2; CARM1, coactivator-associated
  arginine methyltransferase 1; CBP, CREB binding protein; CDC25A, cell division cycle
  25A; CDK2, cyclin-dependent kinase 2; CDK4, cyclin-dependent kinase 4; CDK6, cyclin-dependent
  kinase 6; C-Myc, avian myelocytomatosis viral oncogene homolog; Cul2, cullin 2;
  DeMe, demethylation; DNMT1, DNA (cytosine-5-)-methyltransferase 1; DP1, transcription
  factor DP-1, TFDP1; E2F1, E2F transcription factor 1; DREAM, dimerization partner,
  RB-like, E2F and multi-vulval class B; E2F4, E2F transcription factor 4; E2F6, E2F
  transcription factor 6; E6AP, E6-associated protein, ubiquitin protein ligase E3A,
  UBE3A; E-Cadherin, epithelial cadherin; EGFR, epidermal growth factor receptor;
  EMT, epithelial mesenchymal transition; ERK1/2, mitogen-activated protein kinase
  1/2; ET-1, endothelin 1; ETAR, endothelin A receptor; F-actin, filamentous actin;
  FOXM1, forkhead box M1; HCF-1, host cell factor 1; HLA-E, HLA class I histocompatibility
  antigen, alpha chain E; KDM6A, lysine demethylase 6A; KDM6B, lysine demethylase
  6B; LIN54, protein lin-54 homolog; Me, methylation; MuvB, MuvB complex of five proteins
  including LIN9, LIN37, LIN52, RBBP4 and LIN54; NHERF-1, Na+/H+ exchanger regulatory
  factor; NK, natural killer; O-GlcNAc, O-Linked β-N-acetylglucosamine; OGT, protein
  O-GlcNAc transferase; p16, p16INK4A, p14ARF, cyclin dependent kinase inhibitor 2A,
  CDKN2A; p21, p21WAF1/CIP1, cyclin-dependent kinase inhibitor 1A, CDKN1A; p27, p27KIP1,
  cyclin dependent kinase inhibitor 1B, CDKN1B; p53, tumor protein p53, TP53; p300,
  E1A binding protein p300; P-Cadherin, placental cadherin; PI3K, phosphoinositide
  3-kinase; pRb, phosphorylated retinoblastoma transcriptional corepressor 1; PRMT1,
  protein arginine N-methyltransferase 1; Raf, Raf proto-oncogene, serine/threonine
  kinase; Ras, RAS proto-oncogene, GTPase; STAT3, signal transducers and activators
  of transcription 3; Ub, ubiquitination.
papertitle: Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for
  HPV-Induced Cancers.
reftext: Zhen Dong, et al. Front Immunol. 2020;11:586796.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9597425
figid_alias: PMC7820759__F4
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Bombyx mori
redirect_from: /figures/PMC7820759__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7820759__fimmu-11-586796-g004.html
  '@type': Dataset
  description: Schematic view of the molecular network and functions of human papillomavirus
    (HPV) E5, E6, and E7 oncoproteins in HPV-induced cancers. E5, E6, and E7 oncoproteins
    are responsible for the carcinogenesis and tumorigenesis of HPV-induced cancers
    via activating multiple signaling pathways, such as cell cycle signaling, EGFR
    pathway, migration, and invasion pathways, p53 pathway and some epigenetic pathway.
    AKT, AKT serine/threonine kinases; B-MYB, MYB proto-oncogene like 2, MYBL2; CARM1,
    coactivator-associated arginine methyltransferase 1; CBP, CREB binding protein;
    CDC25A, cell division cycle 25A; CDK2, cyclin-dependent kinase 2; CDK4, cyclin-dependent
    kinase 4; CDK6, cyclin-dependent kinase 6; C-Myc, avian myelocytomatosis viral
    oncogene homolog; Cul2, cullin 2; DeMe, demethylation; DNMT1, DNA (cytosine-5-)-methyltransferase
    1; DP1, transcription factor DP-1, TFDP1; E2F1, E2F transcription factor 1; DREAM,
    dimerization partner, RB-like, E2F and multi-vulval class B; E2F4, E2F transcription
    factor 4; E2F6, E2F transcription factor 6; E6AP, E6-associated protein, ubiquitin
    protein ligase E3A, UBE3A; E-Cadherin, epithelial cadherin; EGFR, epidermal growth
    factor receptor; EMT, epithelial mesenchymal transition; ERK1/2, mitogen-activated
    protein kinase 1/2; ET-1, endothelin 1; ETAR, endothelin A receptor; F-actin,
    filamentous actin; FOXM1, forkhead box M1; HCF-1, host cell factor 1; HLA-E, HLA
    class I histocompatibility antigen, alpha chain E; KDM6A, lysine demethylase 6A;
    KDM6B, lysine demethylase 6B; LIN54, protein lin-54 homolog; Me, methylation;
    MuvB, MuvB complex of five proteins including LIN9, LIN37, LIN52, RBBP4 and LIN54;
    NHERF-1, Na+/H+ exchanger regulatory factor; NK, natural killer; O-GlcNAc, O-Linked
    β-N-acetylglucosamine; OGT, protein O-GlcNAc transferase; p16, p16INK4A, p14ARF,
    cyclin dependent kinase inhibitor 2A, CDKN2A; p21, p21WAF1/CIP1, cyclin-dependent
    kinase inhibitor 1A, CDKN1A; p27, p27KIP1, cyclin dependent kinase inhibitor 1B,
    CDKN1B; p53, tumor protein p53, TP53; p300, E1A binding protein p300; P-Cadherin,
    placental cadherin; PI3K, phosphoinositide 3-kinase; pRb, phosphorylated retinoblastoma
    transcriptional corepressor 1; PRMT1, protein arginine N-methyltransferase 1;
    Raf, Raf proto-oncogene, serine/threonine kinase; Ras, RAS proto-oncogene, GTPase;
    STAT3, signal transducers and activators of transcription 3; Ub, ubiquitination.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mapk3
  - Mapk1
  - Zhx2
  - Akt1
  - Hcfc1
  - Hcif1
  - Itk
  - Slc22a3
  - pk
  - ras
  - Hras
  - Kras
  - Rem1
  - Egfr
  - Edn1
  - Ednra
  - Ogt
  - Nherf1
  - Cdh1
  - Fzr1
  - Cdh3
  - Stat3
  - Carm1
  - Cp
  - Prmt1
  - Kdm6b
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Kdm6a
  - Cul2
  - Cdk2
  - Dnmt1
  - E2f6
  - Cdkn2a
  - Cyp2b10
  - Rbm14
  - Cdc25a
  - Pgr
  - Rb1
  - Cdk6
  - Rbl2
  - Nolc1
  - Rab3gap1
  - Rbl1
  - E2f4
  - Cdk4
  - Foxm1
  - E2f1
  - Reep5
  - Tfdp1
  - Kcnip3
  - MAPK3
  - MAPK1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - HCFC1
  - ITK
  - SLC22A3
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - KRAS
  - HRAS
  - NRAS
  - EGFR
  - EDN1
  - EDNRA
  - OGT
  - EOGT
  - POMGNT1
  - POMGNT2
  - NHERF1
  - CDH1
  - FZR1
  - CDH10
  - CDH11
  - CDH12
  - CDH13
  - CDH15
  - CDH16
  - CDH17
  - CDH18
  - CDH19
  - CDH2
  - CDH20
  - CDH22
  - CDH24
  - CDH3
  - CDH4
  - CDH5
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - STAT3
  - CARM1
  - UBE3A
  - CP
  - PRMT1
  - KDM6B
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - KDM6A
  - CUL2
  - CDK2
  - DNMT1
  - HLA-E
  - CCNE1
  - CCNE2
  - E2F6
  - CDKN2A
  - H3P10
  - CCNA1
  - CCNA2
  - CDC25A
  - RB1
  - CDK6
  - RBL2
  - NOLC1
  - RAB3GAP1
  - RBL1
  - E2F4
  - CDK4
  - FOXM1
  - E2F1
  - UBE2L3
  - PTGDR
  - TFDP1
  - REEP5
  - KCNIP3
  - raf
  - USP
  - O
---
